Lit Matters #1: High vs. Low Dose IV Insulin for Asymptomatic Hyperglycemia

Asymptomatic hyperglycemia in the ED rarely needs aggressive IV insulin just to improve a discharge glucose. In non-emergent hyperglycemia, giving more than 5 units IV lowered glucose more than 5 units or less, but did not shorten ED length of stay and still carried a meaningful hypokalemia signal.

IV Insulin for ED Hyperglycemia

• Non-emergent hyperglycemia framing: Asymptomatic hyperglycemia is not DKA, and the key management question is clinical benefit rather than how fast the number falls.
• Dose comparison cutoff: Using more than 5 units of IV regular insulin produced a larger glucose drop than 5 units or less, but that extra reduction did not translate into a shorter ED stay.
• Length of stay reality: Median ED length of stay was 240 minutes in both groups, a practical reminder that pushing the glucose down faster does not necessarily move disposition.
• Electrolyte downside: Hypokalemia showed up in about 8% of patients despite this being a non-emergent population, which makes IV regular insulin less benign than it often feels at the bedside.
• Fluids and renal function: More than 2 liters of IV fluids tracked with bigger glucose reduction, while better renal function tracked with a smaller drop. We get into why that matters for bedside decision-making in the episode.
• Practice goal check: The real question is what you are trying to accomplish before discharge, because a lower glucose number alone did not produce a measurable operational benefit.